Inventor

WAGNER CLAUDIA

DE50 patents

⚠️ This page may combine multiple inventors who share the name “WAGNER CLAUDIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WAGNER CLAUDIA

IMMATICS BIOTECHNOLOGIES GMBH

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

T cell receptors and immune therapy using the same

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

T cell receptors and immune therapy using the same

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

T cell receptors and immune therapy using the same against prame positive cancers

Engineered T cell receptors and immune therapy using the same

T cell receptors and immune therapy using the same

T cell receptors and immune therapy using the same

T cell receptors and immune therapy using the same

T cell receptors and immune therapy using the same

T cell receptors with improved pairing

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

T cell receptors and immune therapy using the same

T cell receptors and immune therapy using the same against PRAME positive cancers

T cell receptors and immune therapy using the same against PRAME positive cancers

Engineered T cell receptors and immune therapy using the same

Antigen binding proteins specifically binding MAGE-A

T cell receptors with improved pairing

T cell receptors and immune therapy using the same

Engineered T cell receptors and immune therapy using the same

Antigen binding proteins specifically binding MAGE-A

Antigen binding proteins specifically binding PRAME

Method for high throughput peptide-MHC affinity screening for TCR ligands

Antigen binding proteins specifically binding PRAME

Antigen binding proteins specifically binding CT45

Anti-WT1/HLA-specific antibodies

IMMATICS US INC

Methods for manufacturing T cells by direct sorting and compositions thereof